🚀 VC round data is live in beta, check it out!
Thermo Fisher Scientific Valuation Multiples
Discover revenue and EBITDA valuation multiples for Thermo Fisher Scientific and similar public comparables like Siemens, Abbott, Intuitive Surgical, Danaher and more.
Thermo Fisher Scientific Overview
About Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Founded
1956
HQ
Employees
125.0K
Website
Financials (LTM)
EV
$220B
Thermo Fisher Scientific Financials
Thermo Fisher Scientific reported last 12-month revenue of $45B and EBITDA of $11B.
In the same LTM period, Thermo Fisher Scientific generated $19B in gross profit, $11B in EBITDA, and $9B in net income.
Revenue (LTM)
Thermo Fisher Scientific P&L
In the most recent fiscal year, Thermo Fisher Scientific reported revenue of $45B and EBITDA of $12B.
Thermo Fisher Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $45B | XXX | $45B | XXX | XXX | XXX |
| Gross Profit | $19B | XXX | $18B | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 41% | XXX | XXX | XXX |
| EBITDA | $11B | XXX | $12B | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 22% | XXX | XXX | XXX |
| Net Profit | $9B | XXX | $9B | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Debt | — | — | $30B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Thermo Fisher Scientific Stock Performance
Thermo Fisher Scientific has current market cap of $191B, and enterprise value of $220B.
Market Cap Evolution
Thermo Fisher Scientific's stock price is $514.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $220B | $191B | 3.7% | XXX | XXX | XXX | $23.25 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialThermo Fisher Scientific Valuation Multiples
Thermo Fisher Scientific trades at 4.9x EV/Revenue multiple, and 19.4x EV/EBITDA.
EV / Revenue (LTM)
Thermo Fisher Scientific Financial Valuation Multiples
As of April 14, 2026, Thermo Fisher Scientific has market cap of $191B and EV of $220B.
Equity research analysts estimate Thermo Fisher Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Thermo Fisher Scientific has a P/E ratio of 21.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $191B | XXX | $191B | XXX | XXX | XXX |
| EV (current) | $220B | XXX | $220B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | 4.9x | XXX | XXX | XXX |
| EV/EBITDA | 19.4x | XXX | 19.2x | XXX | XXX | XXX |
| EV/EBIT | 21.7x | XXX | 22.1x | XXX | XXX | XXX |
| EV/Gross Profit | 11.7x | XXX | 12.1x | XXX | XXX | XXX |
| P/E | 21.8x | XXX | 22.1x | XXX | XXX | XXX |
| EV/FCF | 33.4x | XXX | 34.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Thermo Fisher Scientific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Thermo Fisher Scientific Margins & Growth Rates
Thermo Fisher Scientific's revenue in the last 12 month grew by 5%.
Thermo Fisher Scientific's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Thermo Fisher Scientific's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Thermo Fisher Scientific's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Thermo Fisher Scientific Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Thermo Fisher Scientific Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Thermo Fisher Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Siemens | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott | XXX | XXX | XXX | XXX | XXX | XXX |
| Intuitive Surgical | XXX | XXX | XXX | XXX | XXX | XXX |
| Danaher | XXX | XXX | XXX | XXX | XXX | XXX |
| Stryker | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Thermo Fisher Scientific M&A Activity
Thermo Fisher Scientific acquired XXX companies to date.
Last acquisition by Thermo Fisher Scientific was on XXXXXXXX, XXXXX. Thermo Fisher Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Thermo Fisher Scientific
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialThermo Fisher Scientific Investment Activity
Thermo Fisher Scientific invested in XXX companies to date.
Thermo Fisher Scientific made its latest investment on XXXXXXXX, XXXXX. Thermo Fisher Scientific invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Thermo Fisher Scientific
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Thermo Fisher Scientific
| When was Thermo Fisher Scientific founded? | Thermo Fisher Scientific was founded in 1956. |
| Where is Thermo Fisher Scientific headquartered? | Thermo Fisher Scientific is headquartered in United States. |
| How many employees does Thermo Fisher Scientific have? | As of today, Thermo Fisher Scientific has over 125K employees. |
| Who is the CEO of Thermo Fisher Scientific? | Thermo Fisher Scientific's CEO is Marc N. Casper. |
| Is Thermo Fisher Scientific publicly listed? | Yes, Thermo Fisher Scientific is a public company listed on NYSE. |
| What is the stock symbol of Thermo Fisher Scientific? | Thermo Fisher Scientific trades under TMO ticker. |
| When did Thermo Fisher Scientific go public? | Thermo Fisher Scientific went public in 1972. |
| Who are competitors of Thermo Fisher Scientific? | Thermo Fisher Scientific main competitors are Siemens, Abbott, Intuitive Surgical, Danaher. |
| What is the current market cap of Thermo Fisher Scientific? | Thermo Fisher Scientific's current market cap is $191B. |
| What is the current revenue of Thermo Fisher Scientific? | Thermo Fisher Scientific's last 12 months revenue is $45B. |
| What is the current revenue growth of Thermo Fisher Scientific? | Thermo Fisher Scientific revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Thermo Fisher Scientific? | Current revenue multiple of Thermo Fisher Scientific is 4.9x. |
| Is Thermo Fisher Scientific profitable? | Yes, Thermo Fisher Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Thermo Fisher Scientific? | Thermo Fisher Scientific's last 12 months EBITDA is $11B. |
| What is Thermo Fisher Scientific's EBITDA margin? | Thermo Fisher Scientific's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Thermo Fisher Scientific? | Current EBITDA multiple of Thermo Fisher Scientific is 19.4x. |
| What is the current FCF of Thermo Fisher Scientific? | Thermo Fisher Scientific's last 12 months FCF is $7B. |
| What is Thermo Fisher Scientific's FCF margin? | Thermo Fisher Scientific's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Thermo Fisher Scientific? | Current FCF multiple of Thermo Fisher Scientific is 33.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.